Small Molecules discovery service deals with early-stage research, which begins with target identification and finally delivers the drug candidate. It starts by using in vitro toxicology and integrates drug discovery, including related chemistry, biology, and safety assessment. Due to their small size, the drugs can penetrate easily to intracellular sites and reach the targets easily compared to larger biological therapies.